Back to results
US 2024/0197776 A1Published application
Cancer-killing cells
OwnerAlex Blyth, Nico Bruyniksinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to an in vitro culture of haematopoietic cells, wherein said haematopoietic cells differentiate to form granulocytes characterised by the ability to kill cancer cells. The invention also relates to said granulocytes, methods for identifying said haematopoietic cells and granulocytes, compositions and kits comprising the same, as well as uses of the same for treating cancer.
Claims21
1-28. (canceled)
A method for treating a cancer comprising:
- administering to a subject in need thereof a therapeutically effective amount of a composition comprising a granulocyte precursor cell derived ex vivo from a haematopoietic cell.
A pharmaceutical composition comprising:
- a. a granulocyte precursor cell derived ex vivo from a haematopoietic cell;
- and
- b. a carrier.
A kit comprising:
- a. a granulocyte precursor cell derived ex vivo from a haematopoietic cell;
- and
- b. instructions for use of the same in medicine.
Dependencies are inferred from the claim text.